HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ulta Projects Continuing Makeup Headwinds, Lowers Guidance For Fiscal 2019

Executive Summary

Over the fiscal 2019 first half, “we've continued to expand our market share across most categories, increased our brand awareness, delivered double-digit growth in active loyalty members, increased traffic and delivered double-digit growth in almost every key merchandise category,” said Ulta CEO Mary Dillon 29 August. However, worsening makeup trends have induced the firm to reset full-year targets.

You may also be interested in...



Eldest Kardashian Sis Launching CBD Serum With Hora Skincare

Kourtney of the “Keeping Up With” clan has partnered with Hora Skincare to launch Hyaluronic Halo + CBD Serum. Announced 6 September, the $50 product will be available exclusively through Kardashian’s Poosh lifestyle platform.

Lauder CFO On China, Hong Kong Unrest And ‘Most Disruptive Market,’ The US

The Estee Lauder Companies has been working to realign its US business in order to meet consumers where they increasingly shop, while contending with a massive influx of indie brands. CFO Tracey Travis discussed US challenges, as well as the company’s continued optimism about China, at the Barclays Global Consumer Staples Conference 4 September.

Lauder Forecasts 7%-8% Sales Growth In FY 2020 Despite Cooling In Key Markets

Amid global recession fears, Lauder anticipates continued double-digit growth in fiscal 2020 in China and travel retail, albeit at slower rates than seen in recent years. The firm booked 9% reported sales growth to roughly $14.9bn for the fiscal 2019 full year, fueled by a record-setting innovation program.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel